BioSpace News Archive

OBN (UK) Ltd., the membership organisation that supports the life sciences industry, is delighted to announce the winners of the 2019 OBN Awards.

The Lung Cancer Research Foundation® announced the awardees of its 2019 Scientific Grant Program during the Fourteenth Annual Lung Cancer Awareness Luncheon, held at The Pierre in New York City.

ThermoGenesis Holdings, Inc. announced it will delay its third quarter ended September 30, 2019 earnings release and conference call, previously scheduled for today, Tuesday, November 12, 2019.

Allakos Inc., a biotechnology company developing antolimab for the treatment of eosinophil and mast cell related diseases, reported financial results for the third quarter ended September 30, 2019.

Cara Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, announced company management will present a corporate overview at two investor conferences in November:

Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, reported financial results for the quarter ended September 30, 2019.

Nabriva Therapeutics plc announced its financial results for the three and nine months ended September 30, 2019 and recent corporate highlights.

Third Quarter 2019 NUZYRA® (omadacycline) Net Sales increased 82% versus the Prior Quarter to $3.1 Million

Optinose reported financial results for the quarter ended September 30, 2019, and provided recent operational highlights.

Marrone Bio Innovations, Inc., an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the third quarter and first nine months ended September 30, 2019.